MENU
CDXS
AS OF
Dec 24 closing price
Price
$1.68
Change
+$0.03 (+1.82%)
Capitalization
151.74M
63 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CDXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Codexis (CDXS) Ownership - Who owns Codexis?

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
151.74M
P/E Ratio
N/A
Total Cash
58.7M
Projected Growth
N/A
Total Debt
68.62M
Revenue
52.93M
Risk (Beta)
3.98
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
0.62 USD as % of share price

Fundamentals

CDXS
Capitalization
152M
P/E Ratio
N/A
Risk (Beta)
3.98
Dividend Yield
N/A
Total Cash
58.7M
Total Cash/Share
0.65
Total Debt
68.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.62%
Revenue
52.9M
ROE
N/A
Book Value
38.5M
P/B Ratio
3.94
Cash Flow
N/A
Earnings
-0.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
4.12
Current Revenue Per Employee
45750.00
Dividends Per Share - Security
N/A
EBITDA
-55.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
71.34
Revenue To Assets
-47.00
Shares Held By Institutions
223M
Shares Outstanding - Current
90.3M
Total Liabilities
85.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-64.780
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CDXS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CDXS showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CDXS
A.I. Advisor
published General Information

General Information

a developer of biocatalytic chemical processes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com